Helmerich & Payne: UBS initiates coverage with buy rating and $49 target price
HP•UBS initiated coverage of Helmerich & Payne with a buy rating and a $49 target price.
Related News
Nasdaq Inc: BofA Global Research cuts price objective to $132 from $135
NDAQ•
WPP expects 2026 LFL revenue less pass-through costs to fall low-to-mid single digits in H2
WPP•
WELL Health to present at Cantech Investment Conference
WELL•
Integra LifeSciences slides after lowering annual forecasts
IART•
Nasdaq trade halt continues; reason unavailable at 9:41 a.m.
UCFI•